SNDX peer analysis
Syndax Pharmaceuticals (SNDX) against its competitors: price, today's move, 1-year return and market value side by side.
- SNDX's peers: ALXO (ALX Oncology), CTMX (CytomX Therapeutics), MGNX (MacroGenics), NRIX (Nurix Therapeutics), NUVB (Nuvation Bio), ORIC (Oric), RCUS (Arcus Biosciences), REPL (Replimune).
SNDX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALXO ALX Oncology | $1.06 | 3.92% | -27.89% | $137.03M |
| CTMX CytomX Therapeutics | $2.04 | -0.34% | -43.72% | $445.41M |
| MGNX MacroGenics | $1.98 | -0.01% | 39.43% | $126.53M |
| NRIX Nurix Therapeutics | $12.85 | -5.51% | -10.33% | $1.40B |
| NUVB Nuvation Bio | $3.80 | -0.26% | -46.85% | $1.34B |
| ORIC Oric | $7.37 | -4.29% | -35.80% | $765.98M |
| RCUS Arcus Biosciences | $15.50 | -1.77% | -23.34% | $2.23B |
| REPL Replimune | $19.09 | -0.73% | 118.42% | $1.81B |
| XNCR Xencor | $33.24 | -2.26% | 110.78% | $2.49B |
| ZYME Zymeworks | $26.14 | -2.68% | 15.66% | $1.81B |
| SNDX Syndax Pharmaceuticals | $8.72 | -4.49% | -47.82% | $785.05M |